Eli Lilly

weight loss scale weigh measure tape obesity overweight

Lilly rounds out orforglipron data ahead of obesity filings

With a complete weight loss data set in hand, Lilly is eyeing regulatory filings for orforglipron and thinks approvals could start arriving next year.

Fraiser Kansteiner Sep 17, 2025 9:00am

Eli Lilly reconsiders UK biotech incubator

Sep 12, 2025 12:09pm

Machine learning artificial intelligence AI database

Lilly invites biotechs to use AI platform to develop their drugs

Sep 9, 2025 7:43am

Lilly ends 2 midstage trials for oral GLP-1 drug naperiglipron

Sep 2, 2025 4:32am

FDA considers new liver trial endpoint, sending MASH shares up

Aug 28, 2025 11:25am

Lilly's oral GLP-1 charts 10.5% weight loss in diabetic patients

Aug 26, 2025 6:45am